4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MetaVia Inc. (MTVA) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 8 employees. Its market capitalization is roughly $9 million. In the fiscal year ended 2025-12-31, MTVA reported $0M in revenue and ($13M) in net income.
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($14M) | ($29M) | ($16M) | ($11M) | — |
| Net Income | ($13M) | ($28M) | ($12M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($2M) | ($4M) | ($4M) | ($4M) |
| Net Income | ($4M) | ($2M) | ($3M) | ($4M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $11M | $16M | $23M | $34M | — |
| Total Liabilities | $6M | $8M | $6M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MTVA viewer.
About TickerBase · Data methodology & sources